Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.47 |
| ▸ | HNF4A | P41235 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30028907 | 0.86 | ALDH1A1 (0.72) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| SCHEMBL36145 | 0.86 | ALDH1A1 (0.72) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| SCHEMBL28724984 | 0.86 | ALDH1A1 (0.61) | ALDH1A1TSHRALOX15CYP3A4CYP2C9 | |
| Bicarbonate SCHEMBL4865957 | 0.84 | CYP2A6 (0.59) | ALDH1A1TSHRCES2CES1MEN1 | |
| Hydrochloric Acid SCHEMBL10888462 | 0.84 | ALDH1A1 (0.68) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| SCHEMBL28408894 | 0.84 | ALDH1A1 (0.68) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| Hydrochloric Acid SCHEMBL7579852 | 0.84 | ALDH1A1 (0.68) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| Hydrochloric Acid SCHEMBL1681943 | 0.84 | ALDH1A1 (0.68) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 | |
| Bicarbonate SCHEMBL11009844 | 0.84 | CYP2A6 (0.59) | ALDH1A1TSHRCES2CES1MEN1 | |
| SCHEMBL2830888 | 0.84 | ALDH1A1 (0.68) | ALDH1A1ALOX15CYP3A4CYP2C9ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117981493-A | Light-emitting element, method for manufacturing light-emitting element, display device, and method for manufacturing display device | 夏普显示科技株式会社 | 2024-05-03 | — | — | CN | claimed |
| WO-2023079616-A1 | LIGHT EMITTING ELEMENT, PRODUCTION METHOD FOR LIGHT EMITTING ELEMENT, DISPLAY DEVICE, AND PRODUCTION METHOD FOR DISPLAY DEVICE | シャープディスプレイテクノロジー株式会社 | 2023-05-11 | — | — | WO | claimed |
| CN-111662184-A | Synthetic method of boscalid intermediate 2- (4' -chlorphenyl) aniline | 广东广康生化科技股份有限公司 | 2020-09-15 | — | — | CN | claimed |
| EP-0057141-B1 | ESTERS OF HALOGENE-BIPHENYLCARBOXYLATES, METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINES | PIERRE FABRE S.A. (FR) | 1984-04-04 | — | — | EP | claimed |
| CN-117981493-A | Light-emitting element, method for manufacturing light-emitting element, display device, and method for manufacturing display device | 夏普显示科技株式会社 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023079616-A1 | LIGHT EMITTING ELEMENT, PRODUCTION METHOD FOR LIGHT EMITTING ELEMENT, DISPLAY DEVICE, AND PRODUCTION METHOD FOR DISPLAY DEVICE | シャープディスプレイテクノロジー株式会社 | 2023-05-11 | — | — | WO | disclosed |
| CN-111662184-A | Synthetic method of boscalid intermediate 2- (4' -chlorphenyl) aniline | 广东广康生化科技股份有限公司 | 2020-09-15 | — | — | CN | disclosed |
| EP-2079690-B1 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2010-09-15 | — | — | EP | disclosed |
| US-20100016401-A1 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | Actelion Phamaceuticals Ltd. (CH) | 2010-01-21 | — | — | US | disclosed |
| EP-2079690-A2 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008087611-A2 | PYRROLIDINE- AND PIPERIDINE- BIS-AMIDE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008038251-A2 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2008-04-03 | — | — | WO | disclosed |
| EP-0807255-A4 | LIPOSOME-ENHANCED IMMUNOAGGREGATION ASSAY AND TEST DEVICE | CORNELL RES FOUNDATION INC (US) | 2000-05-24 | — | — | EP | disclosed |
| US-5958791-A | Interdigitated electrode arrays for liposome-enhanced immunoassay and test device | INNOVATIVE BIOTECHNOLOGIES, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| US-5756362-A | TESTING AND QUANTIFICATION OF A SAMPLE, INCUBATION AND DETECTION | CORNELL RESEARCH FOUNDATION, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5753519-A | Liposome-enhanced immunoaggregation assay and test device | CORNELL RESEARCH FOUNDATION, INC. (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0807255-A1 | LIPOSOME-ENHANCED IMMUNOAGGREGATION ASSAY AND TEST DEVICE | CORNELL RESEARCH FOUNDATION, INC. (US) | 1997-11-19 | — | — | EP | disclosed |
| US-5580741-A | INCUBATING SAMPLE SOLUTION IN CONTAINER PRECOATED WITH ANTIBODY AND PROTEIN CONJUGATE YIELDS COMPLEXES, THEN REMOVAL AND REACTION WITH CHEMILUMINESCENT REAGENTS FOR MEASUREMENT OF LIGHT INTENSITY, FOR CHLORINATED BIPHENYLS | GENERAL ELECTRIC COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| WO-1996024062-A1 | LIPOSOME-ENHANCED IMMUNOAGGREGATION ASSAY AND TEST DEVICE | CORNELL RESEARCH FOUNDATION, INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| EP-0311010-A2 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016401-A1 | 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES | HCRTR1, HCRTR2, CNR1 | ALDH1A1 702/4885TSHR 536/4885ALOX15 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.